You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NOAC

Showing 1 - 25 of 196
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ischemic Strokes While on NOAC - How Compliance Matters

Recruiting
  • Stroke, Ischemic
  • +5 more
    • Hong Kong, Hong Kong
      Chinese University of Hong Kong
    Aug 4, 2022

    Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in

    Active, not recruiting
    • Pleural Effusion
    • Thoracic Effusion
    • Novel Oral Anti-Coagulants
    • New Haven, Connecticut
      Yale New Haven Hospital
    Oct 10, 2022

    Monitoring of NOAC Therapy: Standardizing Reference Intervals

    Recruiting
    • Ischemic Stroke
    • +3 more
      • Hong Kong, Hong Kong
        Chinese University of Hong Kong
      May 18, 2022

      Elderly Belgian NVAF That Are Treated WithNOAC for This

      Completed
      • Non-Valvular Atrial Fibrillation
      • Non-VKA Oral Anticoagulants (NOAC)
      • Multiple Locations, Belgium
        Many Locations
      Mar 21, 2022

      Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)

      Recruiting
      • Ischemic Stroke
      • Anticoagulant Adverse Reaction
      • Dabigatran, rivaroxaban, apixaban, edoxaban
      • Taipei, Taiwan
        National Taiwan University Hospital
      Nov 22, 2023

      Atrial Fibrillation Trial in Xi'an (Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg)

      Recruiting
      • Atrial Fibrillation
      • Rivaroxaban 15mg
      • +4 more
      • Xi'an, Shannxi, China
        Ling Tao
      Jul 24, 2023

      New Oral Anticoagulants (NOAC) in Stroke Patients

      Active, not recruiting
      • Stroke
      • Atrial Fibrillation
      • treatment with NOACs or VKAs
      • Basel, Switzerland
      • +1 more
      Dec 21, 2022

      NOAC Portuguese Real World Study

      Withdrawn
      • Stroke
      • +2 more
      • (no location specified)
      Apr 8, 2022

      Atrial Fibrillation, Percutaneous Coronary Intervention Trial in Xi'an (The WATCHMAN/WATCHMAN FLX device, Rivaroxaban +

      Not yet recruiting
      • Atrial Fibrillation
      • Percutaneous Coronary Intervention
      • The WATCHMAN/WATCHMAN FLX device
      • +2 more
      • Xi'an, Shannxi, China
        Ling Tao
      Jul 20, 2022

      Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)

      Completed
      • Intracerebral Hemorrhage
      • Tranexamic acid
      • Saline 0.9%
      • Basel, Switzerland
        Stroke Center, University Hospital Basel
      Mar 22, 2022

      STEMI - ST Elevation Myocardial Infarction Trial in Zunyi (NOAC+DAPT, DAPT)

      Recruiting
      • STEMI - ST Elevation Myocardial Infarction
      • Zunyi, Guizhou, China
        Affiliated Hospital of Zunyi Medical University
      Aug 25, 2023

      Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Beijing (Aspirin + Clopidogrel +

      Not yet recruiting
      • Coronary Artery Disease
      • +2 more
      • Aspirin + Clopidogrel + Rivaroxaban
      • Aspirin + Clopidogrel
      • Beijing, Beijing, China
        Chinese Academy of Medical Sciences, Fuwai Hospital
      Dec 5, 2022

      Anal Cancer Trial in Worldwide (AMR B: HPV positive ctDNA guided imaging in follow-up)

      Not yet recruiting
      • Anal Cancer
      • AMR B: HPV positive ctDNA guided imaging in follow-up
      • Herlev, Capital Region Of Denmark, Denmark
      • +12 more
      Oct 5, 2022

      Atrial Fibrillation, Coronary Artery Disease, Anticoagulants Trial (Uninterrupted NOAC use, Interrupted NOAC use)

      Not yet recruiting
      • Atrial Fibrillation
      • +2 more
      • Uninterrupted NOAC use
      • Interrupted NOAC use
      • (no location specified)
      Jul 20, 2021

      Aortic Valve Stenosis Trial in Hong Kong, Korea, Republic of, Taiwan (NOAC, DAPT)

      Completed
      • Aortic Valve Stenosis
      • Hong Kong, Hong Kong
      • +4 more
      Nov 5, 2021

      Learn More About Benefits and Side-effects of Drugs Rivaroxaban

      Completed
      • Atrial Fibrillation
      • Rivaroxaban (Xarelto, BAY59-7939)
      • +2 more
      • Many Sites, United Kingdom
        Many facilities
      Oct 27, 2021

      Coronary Artery Disease, Myocardial Ischemia, Myocardial Infarction Trial in Heerlen (Dabigatran + Ticagrelor, Dabigatran +

      Recruiting
      • Coronary Artery Disease
      • +3 more
      • Dabigatran + Ticagrelor
      • Dabigatran + clopidogrel
      • Heerlen, Limburg, Netherlands
        Zuyderland MC
      Apr 29, 2021

      Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)

      Recruiting
      • Atrial Fibrillation
      • NOAC monotherapy
      • Dual therapy with apixaban and clopidogrel
      • Seoul, Korea, Republic of
        Severance Cardiovascular Hospital, Yonsei University Health Syst
      Sep 10, 2021

      Atrial Fibrillation, Coronary Artery Disease Trial in Athens (VKA, NOAC)

      Completed
      • Atrial Fibrillation
      • Coronary Artery Disease
      • Athens, Attika, Greece
        Attikon University Hospital
      Jul 23, 2021

      Atrial Fibrillation Trial in Prague (NOAC, Left atrial appendage closure)

      Completed
      • Atrial Fibrillation
      • NOAC
      • Left atrial appendage closure
      • Prague, Czechia
        Cardiocenter, 3rd Medical School, Charles University and Univers
      Jun 9, 2021

      Upper Gastrointestinal Bleeding Trial in Blacktown, Hong Kong, Singapore (restart NOAC very early, restart NOAC early)

      Recruiting
      • Upper Gastrointestinal Bleeding
      • restart NOAC very early
      • restart NOAC early
      • Blacktown, New South Wales, Australia
      • +2 more
      May 4, 2020

      Specific PoC Testing of Coagulation in Patients Treated With

      Recruiting
      • Anticoagulation With NOAC
      • anti-Xa activity point-of-care testing (aXa-POCT)
      • ecarin clotting time point-of-care testing (ECT-POCT)
      • Tuebingen, Germany
        University Hospital Tuebingen
      Dec 14, 2020

      Non-vitamin K Antagonist Oral Anticoagulant Concentration and

      Recruiting
      • Atrial Fibrillation
      • Data collection
      • Taipei, Please Select, Taiwan
      • +1 more
      Apr 17, 2022

      Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute

      Recruiting
      • Therapeutic Drug Monitoring
      • Blood sampling to test drug level
      • Taipei, Taiwan
        National Taiwan University Hospital
      Mar 8, 2022

      Atrial Fibrillation, Stroke Trial in Worldwide (Left atrial appendage occlusion, NOAC)

      Recruiting
      • Atrial Fibrillation
      • Stroke
      • Left atrial appendage occlusion
      • NOAC
      • Aarhus, Central Denmark Region, Denmark
      • +11 more
      Jan 4, 2021